Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Kaucic

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Methods in Enzymology|November 30, 2006
Modulation of growth factor signaling by gangliosides: positive or negative?Karen Kaucic, Yihui Liu, Stephan Ladisch
Cancer Letters|June 1, 2005
Low complex ganglioside expression characterizes human neuroblastoma cell linesSimone Hettmer, Stephan Ladisch, Karen Kaucic
Cancer Research|November 13, 2003
Biological stratification of human neuroblastoma by complex "B" pathway ganglioside expressionSimone Hettmer, Carolin Malott, William Woods, et al.
Glycoconjugate Journal|April 27, 2011
Induction of GM1a/GD1b synthase triggers complex ganglioside expression and alters neuroblastoma cell behavior; a new tumor cell model of ganglioside functionLixian Dong, Yihui Liu, Anamaris M Colberg-Poley, et al.
Investigational New Drugs|September 19, 2007
Phase I and pharmacokinetic study of etaracizumab (Abegrin), a humanized monoclonal antibody against alphavbeta3 integrin receptor, in patients with advanced solid tumorsCatherine Delbaldo, Eric Raymond, Karina Vera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2009
EBV-related lymphoproliferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignanciesDeirdre O'Mahony, John C Morris, Maryalice Stetler-Stevenson, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Methods in Enzymology|November 30, 2006
Modulation of growth factor signaling by gangliosides: positive or negative?Karen Kaucic, Yihui Liu, Stephan Ladisch
Cancer Letters|June 1, 2005
Low complex ganglioside expression characterizes human neuroblastoma cell linesSimone Hettmer, Stephan Ladisch, Karen Kaucic
Cancer Research|November 13, 2003
Biological stratification of human neuroblastoma by complex "B" pathway ganglioside expressionSimone Hettmer, Carolin Malott, William Woods, et al.
Glycoconjugate Journal|April 27, 2011
Induction of GM1a/GD1b synthase triggers complex ganglioside expression and alters neuroblastoma cell behavior; a new tumor cell model of ganglioside functionLixian Dong, Yihui Liu, Anamaris M Colberg-Poley, et al.
Investigational New Drugs|September 19, 2007
Phase I and pharmacokinetic study of etaracizumab (Abegrin), a humanized monoclonal antibody against alphavbeta3 integrin receptor, in patients with advanced solid tumorsCatherine Delbaldo, Eric Raymond, Karina Vera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2009
EBV-related lymphoproliferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignanciesDeirdre O'Mahony, John C Morris, Maryalice Stetler-Stevenson, et al.
Pageof 1